HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE MARROW TRANSPLANTATION VERSUS DEXAMETHASONE, CISPLATIN, AND CYTARABINE IN AGGRESSIVE NON-HODGKIN’S LYMPHOMA WITH PARTIAL RESPONSE TO FRONT-LINE CHEMOTHERAPY: A PROSPECTIVE RANDOMIZED ITALIAN MULTICENTER STUDY / Martelli, Maurizio; Vignetti, M.; Zinzani, P. L.; Gherlinzoni, F.; Meloni, G.; Fiacchini, M.; DE SANCTIS, Vitaliana; Papa, G.; Martelli, M. F.; Calabresi, F.; Tura, S.; Mandelli, F.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - STAMPA. - (1996).
HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE MARROW TRANSPLANTATION VERSUS DEXAMETHASONE, CISPLATIN, AND CYTARABINE IN AGGRESSIVE NON-HODGKIN’S LYMPHOMA WITH PARTIAL RESPONSE TO FRONT-LINE CHEMOTHERAPY: A PROSPECTIVE RANDOMIZED ITALIAN MULTICENTER STUDY.
MARTELLI, Maurizio;M. Vignetti;DE SANCTIS, Vitaliana;
1996
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.